Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

6988 results

Sort By:

BINGO: Bridging Knowledge, Increasing Awareness

Study ID: NCT06504407
Start Date: 2024-10-28
End Date: 2026-06-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

90

Intervention / Treatment

Bingo Educational Game

Sponsor

Milton S. Hershey Medical Center

Source: clinicaltrials.gov

Share:
Add to list

DT2216 + Paclitaxel in Platinum-Resistant Ovarian Cancer

Study ID: NCT06964009
Start Date: 2025-09-22
End Date: 2027-12-30
Study Type

Interventional

Study Phase

Phase1

No. of Participants

30

Intervention / Treatment

DT2216

Paclitaxel

Sponsor

Elizabeth Stover, MD, PhD

Source: clinicaltrials.gov

Share:
Add to list

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

Study ID: NCT06124157
Start Date: 2025-05-30
End Date: 2030-12-01
Study Type

Interventional

Study Phase

Phase3

No. of Participants

222

Intervention / Treatment

Biospecimen Collection

Blinatumomab

Bone Marrow Biopsy

Calaspargase Pegol

Cyclophosphamide

Cytarabine

Dasatinib

Daunorubicin

Doxorubicin

Echocardiography Test

Imatinib

Leucovorin

Mercaptopurine

Methotrexate

Multigated Acquisition Scan

Pegaspargase

Prednisolone

Prednisone

Radiation Therapy

Thioguanine

Vincristine

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

A Study of Response Adapted Ultra Low Dose 4 Gy Radiation for Definitive Therapy of Marginal Zone Lymphoma

Study ID: NCT05929612
Start Date: 2023-07-28
End Date: 2027-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

50

Intervention / Treatment

Ultra Low Dose 4 Gy Radiation

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Novel Imaging Technique to Assess Gynecologic Cancer

Study ID: NCT04893434
Start Date: 2021-05-13
End Date: 2026-05
Study Type

Interventional

Study Phase

Phase1

No. of Participants

70

Intervention / Treatment

Gadobutrol

MRI

Sponsor

Memorial Sloan Kettering Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Gut Microbiome, Adverse Effects, and Markers Through MEtabolic Reprogramming

Study ID: NCT06536881
Start Date: 2024-08-08
End Date: 2029-05
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

Fasting

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Source: clinicaltrials.gov

Share:
Add to list

A Clinical Trial of BP1002 in Patients With Refractory/Relapsed Acute Myeloid Leukemia (AML)

Study ID: NCT05190471
Start Date: 2022-08-16
End Date: 2027-09
Study Type

Interventional

Study Phase

Phase1

No. of Participants

48

Intervention / Treatment

BP1002; Liposomal Bcl-2 Antisense Oligodeoxynucleotide

Decitabine (in combination with BP1002)

Sponsor

Bio-Path Holdings, Inc.

Source: clinicaltrials.gov

Share:
Add to list

Phase 1 Trial of BTM-3566 in Relapsed/Refractory Mature B Cell Lymphomas

Study ID: NCT06792734
Start Date: 2025-02-14
End Date: 2027-12
Study Type

Interventional

Study Phase

Phase1

No. of Participants

24

Intervention / Treatment

BTM-3566

Sponsor

Bantam Pharmaceuticals

Source: clinicaltrials.gov

Share:
Add to list

A Study Evaluating the Use of an Indoor Air Quality Monitor to Promote a Smoke-free Home

Study ID: NCT06693700
Start Date: 2024-11-14
End Date: 2027-11-14
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

10

Intervention / Treatment

Indoor Air Quality Monitor AirGradient ONE

Sponsor

Memorial Sloan Kettering Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Natural History of KSHV-Associated Multicentric Castleman s Disease

Study ID: NCT04968288
Start Date: 2021-11-17
End Date: 2035-01-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

195

Intervention / Treatment
Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list